Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antidiabetic medication use during pregnancy: an international utilization study.
Cesta CE, Cohen JM, Pazzagli L, Bateman BT, Bröms G, Einarsdóttir K, Furu K, Havard A, Heino A, Hernandez-Diaz S, Huybrechts KF, Karlstad Ø, Kieler H, Li J, Leinonen MK, Gulseth HL, Tran D, Yu Y, Zoega H, Odsbu I. Cesta CE, et al. Among authors: gulseth hl. BMJ Open Diabetes Res Care. 2019 Nov 2;7(1):e000759. doi: 10.1136/bmjdrc-2019-000759. eCollection 2019. BMJ Open Diabetes Res Care. 2019. PMID: 31798900 Free PMC article.
Prevalence and treatment of gestational diabetes in Norway 2010-2020.
Kjerpeseth LJ, Hjellvik V, Gulseth HL, Karlstad Ø, Lopez-Doriga Ruiz P, Wensaas KA, Furu K. Kjerpeseth LJ, et al. Among authors: gulseth hl. Diabetes Res Clin Pract. 2024 Jan;207:111025. doi: 10.1016/j.diabres.2023.111025. Epub 2023 Nov 22. Diabetes Res Clin Pract. 2024. PMID: 38000666 Free article.
Pharmacological treatment of obesity in adults in Norway 2004-2022.
Ruiz PL, Karlstad Ø, Nøkleby K, Slåtsve K, Gulseth HL, Meyer HE, Sveen KA, Qvigstad E, Furu K. Ruiz PL, et al. Among authors: gulseth hl. Diabetes Obes Metab. 2024 Jun;26(6):2102-2110. doi: 10.1111/dom.15515. Epub 2024 Feb 28. Diabetes Obes Metab. 2024. PMID: 38419410
Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis.
Birkeland KI, Jørgensen ME, Carstensen B, Persson F, Gulseth HL, Thuresson M, Fenici P, Nathanson D, Nyström T, Eriksson JW, Bodegård J, Norhammar A. Birkeland KI, et al. Among authors: gulseth hl. Lancet Diabetes Endocrinol. 2017 Sep;5(9):709-717. doi: 10.1016/S2213-8587(17)30258-9. Epub 2017 Aug 3. Lancet Diabetes Endocrinol. 2017. PMID: 28781064
101 results